Seroconversion of children following natural measles infection and vaccination.
OBJECTIVE
To evaluate the relationship between measles virus (MV) antibodies (abs) in sera and breast milk of nursing mothers, their contributions in seroconversion of children (0-9 months) post vaccination, prevalence of prevaccination measles abs in sera of children brought for measles vaccination and seroconversion rate in vaccinees from nursing and lactating mothers. Also to determine the potency of vaccines available in Nigeria in relation to seroconversion.


METHODS
One hundred and twenty pre- and post-vaccination sera and breast milk samples were collected from each nursing mother while corresponding number of finger prick pre- and post-vaccination sera samples were collected from children on filter papers. These were tested for mv abs using serological techniques.


RESULTS
Eighty (20.0%) mothers had measles haemagglutination inhibition (HI) abs in sera and 88 (27.2%) had mv HI abs in breast milk. Eight (2.0%) children who had prevaccination mv abs in sera came from mv ab negative mothers. Forty-four (37.0%) came back for post vaccination sera, sero-converted while 76 (63.3%) gave low sero-conversion rate of 37.0%. Results showed that mv abs in sera or breast milk of mothers did not interfere with mv vaccination in children. The low sero-conversion rate obtained was due to low vaccine potency with titres ranging between (log10-10 - log10-2.5)TCID/per dose, besides non-specific antiviral substances exhibited virus neutralizing activity.


CONCLUSIONS
Poor sero-conversion due to loss of passive immunity arose from undernourishment while low ab titres came with natural infection. This suggested mv vaccination did not immunize following natural mv infection or any other previous immune status.
Odoemele
C F
CF
Department of Virology, College of Medicine, University College Hospital, PMB 5116, Ibadan, Nigeria.
Ukwandu
N C D
NC
Adu
F D
FD
Nmorsi
O P G
OP
Anyanwu
L C
LC
Odike
M A C
MA
Omotade
O O
OO
D000367:Age Factors; D002648:Child; D005260:Female; D006306:Health Surveys; D006801:Humans; D008297:Male; D008457:Measles / Q000097:blood* / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control; D008458:Measles Vaccine; D008895:Milk, Human; D010154:Pakistan / Q000453:epidemiology; D015995:Prevalence; D012307:Risk Factors; D016036:Seroepidemiologic Studies; D011795:Surveys and Questionnaires
D008458:Measles Vaccine